Department of Pediatric Endocrinology, Shandong Provincial Hospital, Shandong University, 9677 Jingshi Road, Lixia Area, 250021, Jinan, Shandong, China.
Department of Pediatrics, Bin Zhou Medical University Hospital, 661 Huangheer Road, 256603, Bin cheng Area, Bin Zhou, Shandong, China.
BMC Pediatr. 2023 Mar 16;23(1):120. doi: 10.1186/s12887-023-03938-x.
Fibroblast growth factor 19 (FGF19) takes part in maintaining the balance of glycolipids and may be involved in complications of type 1 diabetes(T1D) in children. This study aimed at at evaluating the relationship among the levels of serum FGF19 and vascular endothelial growth factor(VEGF)and soluble klotho protein(sklotho) in type 1 diabetic children.
In a cross-section single center study samples were obtained from 96 subjects: 66 T1D and 30 healthy children.Serum FGF19 and VEGF and sklotho concentrations were measured by ELISA. And 66 type 1 diabetes participants were divided into two groups according to T1D duration or three groups according to HbA1c.Furthermore,we compared the serum levels of FGF19 and VEGF and sklotho in different groups.
The concentration of FGF19 was lower in T1D than in the controls(226.52 ± 20.86pg/mu vs.240.08 ± 23.53 pg/L, p = 0.03),while sklotho was also lower in T1D than in the controls (2448.67 ± 791.92pg/mL vs. 3083.55 ± 1113.47pg/mL, p = 0.011). In contrast, VEGF levels were higher in diabetic patients than in controls (227.95 ± 48.65pg/mL vs. 205.92 ± 28.27 pg/mL, p = 0.016). In T1D, FGF19 and VEGF and sklotho was not correlated with the duration of diabetes. FGF19 and VEGF and sklotho were correlated with HbA1c (r=-0.349, p = 0.004 and r = 0.302, p = 0.014 and r=-0.342, p = 0.005, respectively), but not with blood glucose and lipid. Among subjects in the T1D group, concentrations of FGF19,VEGF and sklotho protein were different between different groups according to the degree of HbA1c(P < 0.005).Furthermore, there was a positive correlation between the serum FGF19 concentration and sklotho levels (r = 0.247,p = 0.045), and a negative correlation between the serum FGF19 concentration and VEGF level(r=-0.335,P = 0.006).
The serum FGF19 levels have a close relation with serum VEGF levels and sklotho levels among T1D subjects. FGF19 may be involved in the development of complications in children with type 1 diabetes through interaction with VEGF and sklotho.
成纤维细胞生长因子 19(FGF19)参与维持糖脂平衡,可能与儿童 1 型糖尿病(T1D)的并发症有关。本研究旨在评估 1 型糖尿病儿童血清 FGF19 与血管内皮生长因子(VEGF)和可溶性 klotho 蛋白(sklotho)水平之间的关系。
在一项横断面单中心研究中,我们采集了 96 名受试者的样本:66 名 T1D 患儿和 30 名健康儿童。通过 ELISA 法测定血清 FGF19、VEGF 和 sklotho 浓度。根据 T1D 病程将 66 名 T1D 患儿分为两组,根据 HbA1c 将其分为三组。此外,我们比较了不同组间 FGF19 和 VEGF 及 sklotho 血清水平。
T1D 患儿血清 FGF19 浓度低于对照组(226.52 ± 20.86pg/ml 比 240.08 ± 23.53pg/L,p = 0.03),sklotho 也低于对照组(2448.67 ± 791.92pg/ml 比 3083.55 ± 1113.47pg/ml,p = 0.011)。相比之下,糖尿病患者血清 VEGF 水平高于对照组(227.95 ± 48.65pg/ml 比 205.92 ± 28.27pg/ml,p = 0.016)。在 T1D 中,FGF19 与 VEGF 和 sklotho 与糖尿病病程均无相关性。FGF19 和 VEGF 与 sklotho 与 HbA1c 呈相关(r =-0.349,p = 0.004 和 r =-0.302,p = 0.014 和 r =-0.342,p = 0.005),但与血糖和血脂无关。在 T1D 组受试者中,根据 HbA1c 程度不同,FGF19、VEGF 和 sklotho 蛋白浓度在不同组间存在差异(P<0.005)。此外,血清 FGF19 浓度与 sklotho 水平呈正相关(r =0.247,p =0.045),与 VEGF 水平呈负相关(r =-0.335,p =0.006)。
T1D 患者血清 FGF19 水平与 VEGF 水平和 sklotho 水平密切相关。FGF19 可能通过与 VEGF 和 sklotho 的相互作用,参与儿童 1 型糖尿病并发症的发生。